Management of cytomegalovirus infection and disease in liver transplant recipients

doi:10.4254/wjh.v6.i6.370

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 6

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11698)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

915

WORD

324

HTML

7855

Figures (1-2)

229

Tables (1-4)

226

Sum=9549

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1160

Download

989

Sum=2149

Jun 27, 2014 (publication date) through Nov 6, 2024

Times Cited of This Article

Times Cited (59)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Jun 27, 2014; 6(6): 370-383
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.370

Full Size Figure Download Figure

Figure 2 Time to the onset of cytomegalovirus disease in solid organ transplant recipients who received three mo of oral ganciclovir or valganciclovir prophylaxis. Data obtained from the study by Paya et al[5].

Citation: Bruminhent J, Razonable RR. Management of cytomegalovirus infection and disease in liver transplant recipients. World J Hepatol 2014; 6(6): 370-383
URL: https://www.wjgnet.com/1948-5182/full/v6/i6/370.htm
DOI: https://dx.doi.org/10.4254/wjh.v6.i6.370